丁螺环酮治疗小脑性共济失调

[1] Trouillas P,Xie J,Adeleine P.Treatment of cerebellar ataxia with buspirone: a double-blind study. The Lancet . 1996

[2] Hamon M,Fattaccini CM,Adrien J,et al.Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5hydroxytryptamine1A agonists with potential anxiolytic properties. Japanese Pharmacology and Therapeutics . 1988

[3] Wessel K,Hermsd orfer J,Deger K,et al.Double-blind crossover study with laevorotatory from of hydroxytryptophan in patients with degenerative cerebellar diseases. Archives of Neurology . 1995

[4] Raiteri M,Maura G,Barzizza A.Activation of presynaptic 5hydrotrypataminel-like receptors on glutamatergic terminals inhabits Nmethyl-D-aspartate induced cyclic GMP production in rat cerebellar slices. Journal of Pharmacology and Experimental Therapeutics . 1991

[5] Lou Js,Goldfarb L,McShane L,et al.Use of buspirone for treatment of cerebellar ataxia. Archives of Neurology . 1995

[6] Hinder BC,Mauk MD,Peroutka SJ,et al.Buspirone, 8-OH-DPAT and ipsapirone: effects on hippocampal cerebellar and sciatic fiber excitability. Brain Research . 1988

[7] Yadid G,Sotnik-Barkai I,Tornatore C,et al.Neurochemical alterations in the cerebellum of a murine model of Niemann-Pick type C disease. Brain Research . 1998

[8] Pisani A,Ross WN.Weak effect of neuromodulators on climbing fiberactivated[Ca2+] i increases in rat cerebellar Purkinje neurons. Brain Research . 1999

[9] TrouillasP,XieJ,AdeleineP,etal.Buspirone ,a 5 hydroxytryptamine1Aagonist,isactiveincerebellarataxia. Archives of Neurology . 1 997

[10] Trouillas P,Brudon F,Adeleine P.Improvement of cerebellar ataxia with laevorotatory form of 5-hydrotryptophan. Archives of Neurology . 1988

[1] Trouillas P,Xie J,Adeleine P.Treatment of cerebellar ataxia with buspirone: a double-blind study. The Lancet . 1996

[2] Hamon M,Fattaccini CM,Adrien J,et al.Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5hydroxytryptamine1A agonists with potential anxiolytic properties. Japanese Pharmacology and Therapeutics . 1988

[3] Wessel K,Hermsd orfer J,Deger K,et al.Double-blind crossover study with laevorotatory from of hydroxytryptophan in patients with degenerative cerebellar diseases. Archives of Neurology . 1995

[4] Raiteri M,Maura G,Barzizza A.Activation of presynaptic 5hydrotrypataminel-like receptors on glutamatergic terminals inhabits Nmethyl-D-aspartate induced cyclic GMP production in rat cerebellar slices. Journal of Pharmacology and Experimental Therapeutics . 1991

[5] Lou Js,Goldfarb L,McShane L,et al.Use of buspirone for treatment of cerebellar ataxia. Archives of Neurology . 1995

[6] Hinder BC,Mauk MD,Peroutka SJ,et al.Buspirone, 8-OH-DPAT and ipsapirone: effects on hippocampal cerebellar and sciatic fiber excitability. Brain Research . 1988

[7] Yadid G,Sotnik-Barkai I,Tornatore C,et al.Neurochemical alterations in the cerebellum of a murine model of Niemann-Pick type C disease. Brain Research . 1998

[8] Pisani A,Ross WN.Weak effect of neuromodulators on climbing fiberactivated[Ca2+] i increases in rat cerebellar Purkinje neurons. Brain Research . 1999

[9] TrouillasP,XieJ,AdeleineP,etal.Buspirone ,a 5 hydroxytryptamine1Aagonist,isactiveincerebellarataxia. Archives of Neurology . 1 997

[10] Trouillas P,Brudon F,Adeleine P.Improvement of cerebellar ataxia with laevorotatory form of 5-hydrotryptophan. Archives of Neurology . 1988